Product Images Dasatinib

Each film-coated tablet contains 20 mg of dasatinib. The usual dosage instructions can be found in the package insert, including dosing guidelines, usage directions, and precautions. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). It is important not to use the tablets if the inner seal of the bottle is broken or missing. The medication should be kept in a tightly sealed, light-resistant container with a child-resistant closure, as per USP standards. For safety, keep all medications out of the reach of children. These dasatinib tablets are manufactured in Croatia by Piva Hrvatska d.o.o. and distributed by Teva Pharmaceuticals in Parsippany, NJ. Each bottle contains 60 tablets. It is crucial to swallow the tablets whole and not crush, cut, or chew them. The code "NDC 0480-5101-06" is specified for identification.*

Each film-coated tablet contains 50 mg dasatinib. The usual dosage instructions can be found in the package insert. Store between 20°C to 25°C and excursions permitted between 15°C to 30°C. Ensure the inner seal of the bottle is intact before use. Keep out of reach of children. Do not crush or chew tablets. These tablets should be swallowed whole. Manufactured in Croatia by Teva Pharmaceuticals. Pack contains 60 tablets.*

Each film-coated tablet contains 70 mg dasatinib, with storage instructions provided on the package insert. The dosage and precautions must be followed as indicated. The medication should be kept at temperatures between 20° to 25°C. It is important to ensure the inner seal of the bottle is intact before use and to store the tablets in a tightly sealed, light-resistant container. This medication should be kept out of reach of children. The tablets should not be crushed, cut, or chewed, but rather swallowed whole. This information confirms the important details surrounding the usage and storage of dasatinib tablets.*

This text provides important information about a medication containing 80 mg dasatinib in film-coated tablets. It includes details on the National Drug Code (NDC), storage instructions, dosage guidance, and precautions to consider. The medication should be kept in a controlled room temperature environment and stored in a light-resistant container. It emphasizes not using the tablets if the inner seal is broken, and advises against crushing or chewing the tablets. The manufacturing location is in Croatia, with distribution by Teva Pharmaceuticals. The text also mentions to swallow the tablets whole and to keep all medications out of reach of children.*

Each film-coated tablet contains 100 mg dasatinib. The usual dosage can be found in the package insert for dosing instructions, directions for use, and precautions. It is important to store the medication at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). Make sure not to use if the inner seal of the bottle is broken or missing. Dispense in a tight, light-resistant container with a child-resistant closure. Keep all medications out of reach of children. These tablets should not be crushed, cut, or chewed and must be swallowed whole. The medication is manufactured in Croatia by PVA Hrvatska d.o.o. and manufactured for Teva Pharmaceuticals in Parsippany, NJ 07054. The NDC number for dasatinib tablets is 0480-5104-56.*

Each film-coated tablet contains 140 mg dasatinib. The usual dosage and storage instructions are provided in the package insert. Do not use if the inner seal of the bottle is broken or missing. Keep out of reach of children. The tablets should not be crushed, cut, or chewed; swallow them whole. The medication is manufactured in Croatia and distributed by Teva Pharmaceuticals. The product details include the NDC code 0480-3524-56.*